{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:07:53Z","timestamp":1781298473650,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500400"],"award-info":[{"award-number":["81500400"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.mehy.2018.05.013","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T10:32:30Z","timestamp":1526380350000},"page":"119-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Elevated endogenous opioids in obstructive jaundice: The possible skin mechanisms"],"prefix":"10.1016","volume":"116","author":[{"given":"Xiaoqian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunming","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.mehy.2018.05.013_b0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000440829","article-title":"Pathogenesis and management of pruritus in PBC and PSC","volume":"33","author":"Kremer","year":"2015","journal-title":"Dig Dis"},{"issue":"6","key":"10.1016\/j.mehy.2018.05.013_b0010","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1053\/j.gastro.2014.08.042","article-title":"The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice","volume":"147","author":"Lieu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2018.05.013_b0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mehy.2017.11.002","article-title":"The pruritus of cholestasis: from bile acids to opiate agonists: relevant after all these years","volume":"110","author":"Bergasa","year":"2018","journal-title":"Med Hypotheses"},{"issue":"2 Pt1","key":"10.1016\/j.mehy.2018.05.013_b0020","first-page":"G346","article-title":"Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver","volume":"268","author":"Bergasa","year":"1995","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.mehy.2018.05.013_b0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/ALN.0000000000000210","article-title":"Proteinase-activated receptor 1 contributed to up-regulation of enkephalin in keratinocytes of patients with obstructive jaundice","volume":"121","author":"Tao","year":"2014","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.mehy.2018.05.013_b0030","first-page":"203","article-title":"Assessment of the visual analogue score in the evaluation of the pruritus of cholestasis","volume":"5","author":"Bergasa","year":"2017","journal-title":"J Clin Transl Hepatol"},{"issue":"6","key":"10.1016\/j.mehy.2018.05.013_b0035","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jhep.2005.11.043","article-title":"Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated","volume":"44","author":"Nelson","year":"2006","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.mehy.2018.05.013_b0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000371689","article-title":"Bile acid-induced cholemic nephropathy","volume":"33","author":"Krones","year":"2015","journal-title":"Dig Dis"},{"issue":"6","key":"10.1016\/j.mehy.2018.05.013_b0045","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2006.02.021","article-title":"Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis","volume":"130","author":"Marzioni","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mehy.2018.05.013_b0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1034\/j.1600-0676.2002.01458.x","article-title":"Hepatic met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis","volume":"22","author":"Bergasa","year":"2002","journal-title":"Liver"},{"issue":"3","key":"10.1016\/j.mehy.2018.05.013_b0055","first-page":"2831","article-title":"Adhesion of leukocytes is involved in increased \u03b2-endorphin and elevated pain threshold in obstructive jaundice","volume":"9","author":"Tao","year":"2016","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/j.mehy.2018.05.013_b0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/jid.2010.376","article-title":"Regulated proenkephalin expression in human skin and cultured skin cells","volume":"131","author":"Slominski","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.mehy.2018.05.013_b0065","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.cell.2014.04.032","article-title":"Skin \u03b2-endorphin mediates addiction to UV light","volume":"157","author":"Fell","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.mehy.2018.05.013_b0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/ced.12679","article-title":"Possible role of proenkephalin in psoriasis","volume":"41","author":"Nagui","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2018.05.013_b0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pain.2009.07.016","article-title":"Thrombin receptor: an endogenous inhibitor of inflammatory pain, activating opioid pathways","volume":"146","author":"Martin","year":"2009","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.mehy.2018.05.013_b0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00005-017-0477-3","article-title":"Skin immunity","volume":"66","author":"Matejuk","year":"2018","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"6","key":"10.1016\/j.mehy.2018.05.013_b0085","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1007\/s12035-015-9291-2","article-title":"Signaling mechanism of cannabinoid receptor-2 activation-induced \u03b2-endorphin release","volume":"53","author":"Gao","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.mehy.2018.05.013_b0090","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2009.02137.x","article-title":"Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis","volume":"30","author":"Caraceni","year":"2010","journal-title":"Liver Int"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2018.05.013_b0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.plefa.2008.07.003","article-title":"2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease","volume":"79","author":"Avraham","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6212","key":"10.1016\/j.mehy.2018.05.013_b0100","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.1254229","article-title":"The gentle touch receptors of mammalian skin","volume":"346","author":"Zimmerman","year":"2014","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mehy.2018.05.013_b0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1139\/y98-032","article-title":"Cutaneous Merkel cells of the rat contain both dynorphin A and vesicular monoamine transporter type 1 (VMAT1) immunoreactivity","volume":"76","author":"Weihe","year":"1998","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2018.05.013_b0110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.mehy.2010.03.028","article-title":"Acupuncture and Merkel cells","volume":"75","author":"Silberstein","year":"2010","journal-title":"Med Hypotheses"},{"issue":"10","key":"10.1016\/j.mehy.2018.05.013_b0115","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/exd.13318","article-title":"UVB represses melanocyte cell migration and acts through \u03b2-catenin","volume":"26","author":"Bertrand","year":"2017","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.mehy.2018.05.013_b0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1620\/tjem.211.201","article-title":"Neuroendocrine functions of melanocytes: beyond the skin-deep melanin maker","volume":"211","author":"Takeda","year":"2007","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"10.1016\/j.mehy.2018.05.013_b0120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/bjd.15651","article-title":"Paracrine regulation of melanogenesis","volume":"178","author":"Yuan","year":"2018","journal-title":"Br J Dermatol."},{"issue":"4","key":"10.1016\/j.mehy.2018.05.013_b0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/icb.2015.16","article-title":"The role of chemokines in cutaneous immunosurveillance","volume":"93","author":"Tan","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.mehy.2018.05.013_b0135","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2147\/JPR.S35076","article-title":"Activation of endogenous opioid gene expression in human keratinocytes and fibroblasts by pulsed radiofrequency energy fields","volume":"5","author":"Moffett","year":"2012","journal-title":"J Pain Res"},{"issue":"2","key":"10.1016\/j.mehy.2018.05.013_b0140","first-page":"161","article-title":"Renal function after dopamine and fluid administration in patients with malignant obstructive jaundice. A prospective randomized study","volume":"20","author":"Naranjo","year":"2011","journal-title":"J Gastrointestin Liver Dis"},{"issue":"4","key":"10.1016\/j.mehy.2018.05.013_b0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1517\/14728222.2016.1103735","article-title":"Therapeutic targets for cholestatic liver injury","volume":"20","author":"Woolbright","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.mehy.2018.05.013_b0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-8069-10-10","article-title":"Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation","volume":"10","author":"Sauer","year":"2014","journal-title":"Mol Pain"},{"key":"10.1016\/j.mehy.2018.05.013_b0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fimmu.2016.00293","article-title":"Neuroimmune interaction in the regulation of peripheral opioid-mediated analgesia in inflammation","volume":"7","author":"Hua","year":"2016","journal-title":"Front Immunol"},{"issue":"17","key":"10.1016\/j.mehy.2018.05.013_b0160","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1042\/CS20160326","article-title":"Immune dysfunction in patients with obstructive jaundice before and after endoscopic retrograde cholangiopancreatography","volume":"130","author":"Chowdhury","year":"2016","journal-title":"Clin Sci (Lond)"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718302925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718302925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T12:00:47Z","timestamp":1535112047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987718302925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":32,"alternative-id":["S0306987718302925"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2018.05.013","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated endogenous opioids in obstructive jaundice: The possible skin mechanisms","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2018.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}